发明名称 SIGMA RECEPTOR LIGANDS AND THE USE THEREOF
摘要 2071897 9109594 PCTABS00005 The invention relates to methods for the treatment of schizophrenia or other psychoses by administering a pharmaceutical composition comprising an effective amount of certain sigma receptor ligands to a patient in need of such treatment. The invention further relates to novel sigma receptor ligands having high binding to the sigma receptor and pharmaceutical compositions thereof.
申请公布号 CA2071897(A1) 申请公布日期 1991.06.29
申请号 CA19902071897 申请日期 1990.12.28
申请人 VIRGINIA COMMONWEALTH UNIVERSITY 发明人 GLENNON, RICHARD A.
分类号 A61K31/13;A61K31/135;A61K31/16;A61K31/18;A61K31/19;A61K31/215;A61K31/275;A61K31/40;A61K31/403;A61K31/4035;A61K31/435;A61K31/44;A61K31/445;A61K31/4465;A61K31/451;A61K31/495;A61K31/505;A61K31/535;A61K31/5375;A61K31/55;C07C211/08;C07C211/17;C07C211/27;C07C211/28;C07C211/29;C07C211/30;C07C211/42;C07C215/52;C07C217/16;C07C217/60;C07C219/10;C07C219/12;C07C225/16;C07C229/38;C07C233/04;C07C255/58;C07C317/32;C07C323/32;C07D207/12;C07D209/48;C07D211/14;C07D211/36;C07D211/46;C07D211/52;C07D211/70;C07D223/16;C07D239/42;C07D265/30;C07D295/02;C07D295/03;C07D295/033;C07D295/06;C07D295/073;C07D295/096;C07D295/108;C07D295/192;C07D317/58;C07D471/08;(IPC1-7):C07C211/26;C07D403/06 主分类号 A61K31/13
代理机构 代理人
主权项
地址